Teleflex's recent financials are heavily distorted by non-cash impairment charges, with cumulative net losses exceeding $1.0B in 2025Q3-Q4, yet the underlying business shows signs of stabilization: gross margin expanded to 58.2% in 2026Q2 and operating cash fl...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue volatility persists with a 27.0% YoY decline in 2026Q2, but gross margin improved to 58.2% from 49.5% in 2025Q3, indicating a favorable mix shift despite operating margin compression to 10.6%.
Teleflex offers a wide range of medical technologies across vascular, surgical, anesthesia, and other critical care fields, enhancing its market reach and revenue streams.
With operations in over 150 countries and 14,000 employees, Teleflex has a strong international footprint, supporting consistent growth and market penetration.
Teleflex's potential spin-off of mature and high-growth businesses could unlock strategic value and attract investor interest in differentiated segments.
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 6, 2026 | $1.76+37.5% vs $1.28 | $570M+1.9% vs $560M |
Q2 2026 May 7, 2026 | $1.39+14.9% vs $1.21 | $548M+2.1% vs $537M |
Q1 2026 Feb 26, 2026 | $1.93-48.3% vs $3.73 | $569M-38.1% vs $919M |
Q4 2025 Nov 6, 2025 | $3.67+8.6% vs $3.38 | $913M-0.2% vs $915M |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
TFX, CNC, ENS, ROCK and FAF stand out among five low P/B stocks offering attractive value and promising growth prospects.
VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Teleflex Incorporated (NYSE: TFX) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 8,400 shares of the medical technology company's stock, valued at approximately $1,065,000. Other hedge funds have also recently
Amundi lowered its position in Teleflex Incorporated (NYSE: TFX) by 70.7% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,294 shares of the medical technology company's stock after selling 27,312 shares during the quarter. Amundi's holdings in Teleflex were worth $1,432,000 as
Benchmark TFX against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Teleflex Incorporated (TFX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $124.90 | $5.53B | -6.17 | -34.61% | -45.45% | -24.47% | 1.08% | |
| $3.60 | $14.7M | -0.61 | 814.07% | -795.5% | -162.75% | — | |
| $76.66 | $244.09M | 22.03 | -5.83% | 29.04% | 8.74% | — | |
| $58.83 | $2.99B | -245.13 | 14.88% | 1.85% | 2.14% | — | |
| $16.67 | $1.93B | -13.66 | 8.28% | -21.25% | -44% | — | |
| $15.67 | $647.68M | -17.81 | 9.46% | -11.48% | -21.01% | — |
Teleflex Incorporated (TFX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Teleflex Incorporated (TFX) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 7, 2026·SEC
Aug 6, 2026·SEC
Aug 3, 2026·SEC
Get notified when TFX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Teleflex Incorporated (TFX) stock FAQ — growth, dividends, profitability & financials explained
Teleflex Incorporated (TFX) reported $2.60B in revenue for fiscal year 2025. This represents a 179% increase from $931.2M in 1996.
Teleflex Incorporated (TFX) saw revenue decline by 34.6% over the past year.
Teleflex Incorporated (TFX) reported a net loss of $1.03B for fiscal year 2025.
Yes, Teleflex Incorporated (TFX) pays a dividend with a yield of 1.08%. This makes it attractive for income-focused investors.
Teleflex Incorporated (TFX) has a return on equity (ROE) of -24.5%. Negative ROE indicates the company is unprofitable.
Teleflex Incorporated (TFX) generated $390.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
